Carcinogenesis Advance Access originally published online on July 17, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carcinogenesis, Vol. 24, No. 9, 1481-1487,
September 2003
© 2003 Oxford University Press
CANCER BIOLOGY |
Simultaneous generation of multiple mitochondrial DNA mutations in human prostate tumors suggests mitochondrial hyper-mutagenesis
1 Division of Molecular Epidemiology, National Center for Toxicological Research, Jefferson, AR 72079, USA
2 Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
3 Department of Urology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
4 To whom correspondence should be addressed Email: jjchen{at}nctr.fda.gov
Multiple somatic mitochondrial DNA mutations are frequently reported in human tumors, but the process leading to homoplasmic transformation and accumulation of multiple mutations in the same tumor cell lineage remains a mystery. We address possible mechanisms responsible for the generation of multiple mitochondrial (mt)DNA mutations observed in a high frequency of prostate tumors using sensitive mutant-specific PCR coupled with laser capture microdissection. Analysis of prostate tumors with multiple mtDNA mutations in the control region indicates that the mutations are locally confined, that the multiple mutations exist on the same molecules and that more than one mtDNA mutant species co-exists in the same neoplastic lesion. These results suggest an unusually rapid process in mtDNA mutagenesis during tumor progression. On the basis of prostate tumor cell kinetics, we propose a unique process of mitochondrial hyper-mutagenesis, probably mediated by cellular oxidative stress, to account for a burst of multiple mtDNA mutations in human prostate tumors.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Chen, F. F. Kadlubar, and J. Z. Chen DNA supercoiling suppresses real-time PCR: a new approach to the quantification of mitochondrial DNA damage and repair Nucleic Acids Res., March 13, 2007; (2007) gkm010v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Parr, G. D. Dakubo, K. A. Crandall, J. Maki, B. Reguly, A. Aguirre, R. Wittock, K. Robinson, J. S. Alexander, M. A. Birch-Machin, et al. Somatic Mitochondrial DNA Mutations in Prostate Cancer and Normal Appearing Adjacent Glands in Comparison to Age-Matched Prostate Samples without Malignant Histology J. Mol. Diagn., July 1, 2006; 8(3): 312 - 319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G D Dakubo, R L Parr, L C Costello, R B Franklin, and R E Thayer Altered metabolism and mitochondrial genome in prostate cancer J. Clin. Pathol., January 1, 2006; 59(1): 10 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kim, P. Sun, Y.-W. Lam, P. Troncoso, A. L. Sabichi, R. J. Babaian, L. L. Pisters, C. A. Pettaway, C. G. Wood, S. M. Lippman, et al. Changes in Serum Proteomic Patterns by Presurgical {alpha}-Tocopherol and L-Selenomethionine Supplementation in Prostate Cancer Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1697 - 1702. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.C. WALLACE Mitochondria and Cancer: Warburg Addressed Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 363 - 374. [Abstract] [PDF]
|
|
|
|
 |
|
 W. Zhu, W. Qin, P. Bradley, A. Wessel, C. L. Puckett, and E. R. Sauter Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid Carcinogenesis, January 1, 2005; 26(1): 145 - 152. [Abstract] [Full Text] [PDF]
|
|